Home › NDC Lookup › RxCUI directory › RxCUI 2059274

Omadacycline 150 MG Oral Tablet — RxCUI 2059274

RxNorm drug concept · Semantic clinical drug
RxCUI 2059274 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2059274
Official nameOmadacycline 150 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped2
Package NDCs mapped3
Reported Medicaid activity (SDUD)2,212 prescriptions · 17 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Omadacycline: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • No, Nuzyra is specifically approved for two types of bacterial infections in adults: community-acquired bacterial pneumonia (a lung infection you develop outside a hospital) and ac...
  • What is Nuzyra actually treating — is it for any type of infection?
  • It really does matter with this one. Studies showed that eating a high-fat meal — especially one with dairy — before taking the Nuzyra tablet can cut the amount your body absorbs b...
  • Why do I have to take the tablet on such an empty stomach? That seems strict.
📖 Read our full Omadacycline guide →

🕸️ Concept Web — How Omadacycline 150 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Omadacycline 150 MG Oral Tablet RxCUI 2059274

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Omadacycline 2059269
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Nuzyra 2059275
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Omadacycline Oral Tablet 2059273
    • Omadacycline Oral Product 2059271
    • Omadacycline Pill 2059272
    • Omadacycline Oral Tablet [Nuzyra] 2059277
    • Nuzyra Oral Product 2059278
    • Nuzyra Pill 2059279
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Omadacycline 150 MG SCDC · 2059270
  • Omadacycline Oral Tablet SCDF · 2059273
  • Omadacycline Oral Product SCDG · 2059271
  • Omadacycline Pill SCDG · 2059272

Brand-Name Concepts

  • Omadacycline 150 MG Oral Tablet [Nuzyra] SBD · 2059280
  • Omadacycline 150 MG [Nuzyra] SBDC · 2059276
  • Omadacycline Oral Tablet [Nuzyra] SBDF · 2059277
  • Nuzyra Oral Product SBDG · 2059278
  • Nuzyra Pill SBDG · 2059279
  • Nuzyra BN · 2059275

📦 FDA Products & Package NDCs

2 products · 3 package NDCs
3 package NDCs map to RxCUI 2059274 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
71715-0001-02 10 VIAL, GLASS in 1 CARTON (71715-001-02) / 10 mL in 1 VIAL... NUZYRA Paratek Pharmaceuticals, Inc. 2019-02-01
71715-0002-21 1 BLISTER PACK in 1 CARTON (71715-002-21) / 6 TABLET, FILM... NUZYRA Paratek Pharmaceuticals, Inc. 2020-02-01
71715-0002-27 5 BLISTER PACK in 1 CARTON (71715-002-27) / 6 TABLET, FILM... NUZYRA Paratek Pharmaceuticals, Inc. 2020-02-01
Observed labelers: Paratek Pharmaceuticals, Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J0121 Inj., omadacycline, 1 mg 1 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.